Strategy For The Development Of A Manufacturing Process Of Single Domain Antibody (sdAb)
Source: Polyplus

This application note provides an extensive process development approach for establishing an optimized manufacturing protocol for producing single-domain antibodies (sdAbs) for therapeutic use. It covers the development of microbial expression strains, optimization of upstream and downstream processes, and formulation development, aiming to achieve high-quality (HQ) and good manufacturing practice (GMP) grade production.
access the Application Note!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Polyplus
This website uses cookies to ensure you get the best experience on our website. Learn more